Perrigo | PRGO - Loan Capital




Perrigo reported $4.31B in Loan Capital for its fiscal quarter ending in September of 2024.

Loan Capital Change Date
AbbVie USD 58.75B 401M Sep/2024
Abbott USD 12.82B 388M Sep/2024
Bayer EUR 36.67B 725M Sep/2024
Bristol-Myers Squibb USD 47.6B 1.07B Dec/2024
Corcept Therapeutics USD 6.36M 6.36M Sep/2024
Dr.Reddys Laboratories INR 7.58B 218M Dec/2024
Eli Lilly USD 29.05B 5.32B Sep/2024
J&J USD 31.29B 347M Sep/2024
Merck USD 34.98B 265M Sep/2024
Nestle CHF 51.7B 2.95B Dec/2024
Pacira USD 385.89M 203.41M Sep/2024
Perrigo USD 4.31B 684.7M Sep/2024
Pfizer USD 56.92B 963M Sep/2024
Prestige Brands USD 1000M 60M Dec/2024
Reckitt Benckiser GBP 7.82B 967M Jun/2024
Sanofi 12.5B 1.84B Jun/2024
Supernus Pharmaceuticals USD 0 0 Jun/2024
Teva Pharmaceutical Industries USD 16B 398M Dec/2024
Xeris Pharmaceuticals USD 216.23M 14.25M Sep/2024
Zoetis USD 5.22B 1.35B Dec/2024